Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jose Luis Campo-Cañaveral de la Cruz (Madrid, Spain), Jose Luis Campo-Cañaveral De La Cruz, David Gómez De Antonio, Mercedes Zurita Castillo, Martin Santos González, Carmen González Lois, Andrés Varela de Ugarte. Bone marrow-derived mesenchymal stem cells transplantation in a model of bronchiolitis obliterans. Eur Respir J 2016; 48: Suppl. 60, 4630

Member's Comments

No comment yet.

Related content which might interest you: Bronchiolitis obliterans following haematopoietic stem cell transplantation Source: Eur Respir J 2007; 29: 1007-1019 Year: 2007 Exogenous administration of bone marrow-derived stem cells in experimental COPD Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Intratracheal administration of bone marrow-derived mesenchymal stem cells ameliorates lung function Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated? Source: Eur Respir J 2005; 25: 402-405 Year: 2005 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 LATE-BREAKING ABSTRACT: Temporary improvement of serum albumin in PIZ mice after transplantation of stem cell-derived hepatocyte-like cells Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016 Clinical course of patients with bronchiolitis obliterans after hematopoietic stem cell transplantation Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Effect of extracorporeal photopheresis on respiratory function in hematopoietic stem cell transplant recipients Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Evaluation of pulmonary functions after hematopoietic stem cell transplantation in children Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma Year: 2015 Bone marrow progenitor cells in patients with COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Pulmonary infiltrates in allogenic hematopoietic stem cell transplantation recipients Source: Eur Respir J 2002; 20: Suppl. 38, 476s Year: 2002 Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation Source: Eur Respir J 2011; 38: 470-472 Year: 2011 Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease Year: 2016 Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study Source: Eur Respir J 2005; 25: 490-493 Year: 2005 Chest CT-findings after hematopoietic stem cell transplantation Source: International Congress 2014 – Different modalities and techniques for lung imaging Year: 2014 LSC 2010 Abstract: Does cigarette smoking influence bone marrow microenvironment? Down-regulation of CXCR4 expression in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): preliminary results Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010